Home › Triple-Negative Breast Cancer › Minnesota › Rochester

Pag-aaral pangklinika para sa Triple-Negative Breast Cancer sa Rochester, MN

Isang pag-aaral para sa Triple-Negative Breast Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Rochester. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

PRE-ISPY Phase I/II Oncology Platform Program

Nagre-recruitPhase 1/2

Mayo Clinic Comprehensive Cancer Center, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT05868226

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

Nagre-recruit

Mayo Clinic, Rochester

Edad 30 pataas · Kababaihan · Na-update Set 25, 2026 · NCT02945579

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Nagre-recruitObservasyonal na pag-aaral

Mayo Clinic Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04981119

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

Nagre-recruitPhase 2

Mayo Clinic, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07340541

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Mayo Clinic, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06657222

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Nagre-recruitPhase 3

Mayo Clinic Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT05633654

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

Nagre-recruitPhase 1

Mayo Clinic Rochester, Rochester

Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT06562192

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

Nagre-recruitPhase 1/2

Mayo Clinic - Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT05377996

Phase 1 Study of CLR 125 in Triple Negative Breast Cancer

Nagre-recruitPhase 1

Mayo Clinic Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT07311993

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Nagre-recruitPhase 2

Mayo Clinic, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT01042379

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Nagre-recruitPhase 1/2

Mayo Clinic, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2025 · NCT06682793

Pag-aaral para sa Triple-Negative Breast Cancer sa ibang lungsod

Iba pang pag-aaral sa Rochester

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.